million or 11.6% due to the following reasons: Unit: Million Baht - The cash-base patients’ revenue for Q3/2018 were Baht 1,518.9 million which increased from Q3/2017 by Baht 245.3 million or 19.3% as a

forward on its Balance Sheet Strengthening Strategy and achieved a major milestone during the quarter by successfully issuing Rights Offering for THB 1,503 Million to its shareholders, which was

November 8, 2017) for a period of not more than 2 years from the first draw down date with additional in mortgage value for the same Land, Building, and Machinery Mortgaged in order to use the fund as

as of November 8, 2017) for a period of not more than 2 years from the first draw down date with additional in mortgage value for the same Land, Building, and Machinery Mortgaged in order to use the

quarter ended 30 June 2020, the Company’s SG&A expenses were USD 33.30 million (or equivalent to Baht 1,055.94 million) or 4.67% of the total sales revenue which increased from 4.31% of sales revenue over

follows: Baht’000 Consolidated F/S ∆% Separate F/S ∆% 2019 2018 2019 2018 Revenues from Sales and Services 1,921,477 2,060,114 -7% 1,518,926 1,640,996 -7% Other income 72,604 338,396 -79% 52,158 25,568 104

quarter from the contraction of the industrial sector that reduced the production of industrial products due to higher production costs, a lower domestic demand and lower demands from trading partners in

%. The Company would like to clarify a significance change of Group’s operation results were summarised as follows 1. Revenue from sales and services for the year 2017 decreased by 11% compared to the same

surplus in 2018 with the additional of domestic price decrease from the new sugar regime that domestic price will float along with global price. As a result, the Company recorded average sugar price

revenues from sales and lower expense: details as follow. On June 15, 2016, the Companies entered into a land sale agreement for 1 plot of non-operational land of a subsidiary company together with 4 plots